x-nuclear diagnostic GmbH is a spin-off of University Hospital (Universitätsklinikum) Jena founded in 2019 and based in Erfurt, Germany.

x-nuclear diagnostics GmbH researches on technologies in the field of diagnostic for application in nuclear medicine. In nuclear medical diagnostics, patients are administered radioactive drugs which accumulate in various concentrations in human organs or tissues (depending on their pharmacological properties). Due to their radioactivity, their temporal and spatial distribution in the body can be detected externally and made visible through suitable measuring instruments.

The company’s liver-specific radiotracer for PET diagnostics is in an early stage of development; its effectiveness has been demonstrated in animals (in ovo). The PET tracer has high potential for clinical application because it is less toxic than other radiodiagnostics and can also be used for metal-heavy implants (unlike existing tracers which cannot be used for metal implants). In the DACH region alone there are over 300 nuclear medicine specialists who could also use the PET tracer. If the centers in the US and Asia are included, sales potential is expected to exceedEUR 1 billion per year

‍